Chemistry, a venture capital firm established by former executives from industry giants Bessemer, Index Ventures, and Andreessen Horowitz, is moving forward with plans to raise $500 million for its second investment vehicle. The firm, which debuted just two years ago, has filed documentation with the SEC to initiate the capital raise, signaling a significant expansion of its investment capacity.

The firm was co-founded by Mark Goldberg, Ethan Kurzweil, and Kristina Shen, who leveraged their extensive backgrounds at top-tier venture firms to launch the venture. Chemistry initially entered the market with a $350 million debut fund, focusing its strategy on early-stage startups. The firm has carved out a niche in the artificial intelligence sector, backing companies that specialize in both AI infrastructure and consumer-facing applications.

Chemistry’s current portfolio includes notable startups such as Granola, Decagon, Persona, Serval, and Nova Intelligence. Reports indicate that the new $500 million fund has already seen strong interest from investors and is currently oversubscribed, with a final closing expected in the near future. This momentum underscores the continued appetite for specialized venture capital firms that focus on the rapidly evolving AI landscape.

Key Takeaways

• Chemistry is raising $500 million for its second fund, following an initial $350 million debut fund.
• The firm was founded by former partners from Bessemer, Index Ventures, and Andreessen Horowitz.
• The new fund is reportedly oversubscribed, highlighting strong investor confidence in the firm's AI-focused investment strategy.

Editor’s Analysis & Impact

The successful fundraising efforts of Chemistry highlight a broader trend in the venture capital industry: the rise of ’boutique’ firms led by seasoned veterans from legacy institutions. By focusing specifically on the AI stack—ranging from infrastructure to application layers—Chemistry is positioning itself to capture value in one of the most capital-intensive and high-growth sectors of the decade. The fact that the fund is oversubscribed suggests that limited partners remain eager to deploy capital into specialized, high-conviction managers despite broader macroeconomic uncertainties. As AI continues to mature, firms like Chemistry that possess deep operational and investment experience will likely play a pivotal role in shaping the next generation of enterprise and consumer technology, potentially challenging the dominance of larger, more generalized venture funds.

Frequently Asked Questions

Q: Who are the founders of Chemistry?
A: Chemistry was founded by Mark Goldberg, Ethan Kurzweil, and Kristina Shen, all of whom previously held roles at major venture capital firms including Index Ventures, Bessemer, and Andreessen Horowitz.

Q: What is the primary investment focus of Chemistry?
A: The firm focuses on early-stage startups, with a specific emphasis on companies building within the artificial intelligence sector, including AI infrastructure and applications.